U.S. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing, 2019-2023: Supplier Shares by Country and Segment Forecasts, Emerging Technologies, Competitive Strategies

The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget.

This new study from  contains 430 pages, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years.

Report Highlights

- Market shares of leading suppliers
- Business and technological trends in major markets
- Five-year test volume and sales forecasts
- Market shares of leading competitors
- Feature comparison of major analyzers
- Strategic profiles of leading market players and start-up firms developing innovative products
- Specific product and business opportunities for instrument and consumable suppliers.

Rationale

Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by these markets, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

U.S. Market Overview

- Laboratories performing DNA sequencing and molecular diagnostic testing by country and market segment.

- Five-year test volume and sales projections.

Market Segmentation Analysis

- Five-year test volume and sales projections:

- Infectious Diseases        - Forensic Testing
-Cancer                                - Paternity Testing/HLA Typing
- Genetic Diseases             - Others


  • - A comprehensive analysis of the sequencing market by laboratory segment.

    - Detailed market segmentation analysis, including review of the market dynamics, trends,
      structure, size, growth and major suppliers.

    Product/Technology Review

    - Comparison of the major molecular diagnostic analyzers.

    - Extensive review of molecular diagnostic technologies, test formats, detection methodologies,
      trends in testing automation and over target/signal amplification methods.

    - Worldwide listings of companies, universities and research centers developing new molecular
       diagnostic technologies and products.

    Competitive Assessments

    - Extensive strategic assessments of major suppliers and emerging market entrants,
      including their sales, product portfolios, marketing tactics, collaborative arrangements and
      new technologies/products in R&D.

    - Abbott
    - Affymetrix
    - Agilent Technologies
    - Applied Gene Technologies
    - Arca Biopharma
    - Beckman Coulter/Danaher
    - Becton Dickinson
    - Biokit
    - bioMerieux
    - Bio-Rad
    - Biotest
    - Cepheid
    - Decode Genetics
    - Diadexus
    - Eiken Chemical
    - Elitech Group
    - Enzo Biochem
    - Exact Sciences
    - Fujirebio
    - Grifols
    - Hologic
    - Illumina
    - LabCorp
    - Leica Biosystems
    - Li-Cor Biosciences
    - Myriad Genetics
    - Ortho-Clinical Diagnostics
    - PerkinElmer
    - Proteome Sciences
    - Qiagen
    - Roche
    - Scienion
    - Sequenom
    - Shimadzu
    - Siemens Healthineers
    - Sierra Molecular
    - Takara Bio
    - Tecan Group
    - Thermo Fisher

    - Comprehensive listings of companies developing and marketing molecular
      diagnostic products, by test and application.

    Opportunities and Strategic Recommendations

    - Specific new product development opportunities with potentially significant market appeal
      during the next five years.

    - Design criteria for new products.

    - Alternative market penetration strategies.

    - Potential market entry barriers and risks.

    - Business planning issues and concerns.


Introduction
Global Market Trends and Emerging Technologies
A. DNA Sequencing
B. DNA and RNA Probe Technology

C. Detection Technologies

D. Instrumentation: Review of Automated and Semi-Automated Analyzers
E. Biochips: Genosensors, Microarrays, Labs-on-the-Chip

F. Pharmacogenomics
G. Cancer Molecular Diagnostics Testing
1. Overview
2. Major Cancer Types
3. Oncogenes
H. Genetic Diseases Molecular Diagnostic Testing
1. Overview
2. Nucleic Acid Amplification
3. Chromosome Imaging
4. Genomics Technologies
5. Proteomics Technologies
6. Current Pharmacogenomic Testing
7. Major Diseases
I. Forensic Molecular Diagnostics Testing
1. Overview
2. Multilocus and Single Locus Probes
3. The FBI
(continued)
4. DNA Profile Data Banks
5. Judicial Implementation
6. Major Crime Categories
7. Factors Contributing to the DNA Probe
Major Expansion
J. Paternity Testing/HLA Typing Molecular Diagnostic Testing
K. Other Molecular Diagnostic Testing Applications
L. Competing/Complementing Technologies
U.S.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
- Volume Forecasts by Market Segment
- Sales Forecasts by Market Segment
- Major Supplier Sales and Market Shares
Major Product Development Opportunities
A. Opportunities for New Instrumentation
B. Opportunities for New Reagent Kits and Test Systems/Panels
C. Opportunities for New IT, Computers, Software and Automation
D. Opportunities for New Auxiliary Products
Design Criteria For Decentralized Testing Products
Alternative Market Penetration Strategies
Potential Market Entry Barriers And Risks
Competitive Profiles

- Abbott
- Affymetrix
- Agilent Technologies
- Applied Gene Technologies
(continued)
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- BioMerieux
- Bio-Rad
- Biotest
- Cepheid
- CellMark Forensics/LabCorp
- Decode Genetics
- Diadexus
- Eiken
- Elitech Group
- Enzo
- Exact Sciences
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- Illumina
- Kreatech/Leica
- Li-Cor Biosciences
- Monogram Biosciences
- Myriad Genetics
- Ortho-Clinical Diagnostics
- Perkin Elmer/Caliper
- Proteome Sciences
- Qiagen
- Roche
- Scienion
- Sequenom
- Shimadzu
- Siemens
- Sierra Molecular
- Takara Bio
- Tecan Group
- Thermo Fisher
Appendixes

List Of Tables


Oncogenes Potential Applications in Cancer Diagnosis
Major Companies Developing or Marketing Cancer
Molecular Diagnostic Tests
Major Companies Developing or Marketing Molecular Diagnostic Tests
For Genetic Diseases
U.S.A., Laboratories Performing
DNA Sequencing by Market Segment
U.S.A., Molecular Diagnostics Market, Potential
Laboratory Universe by Market Segment

U.S.A., Molecular Diagnostic Test Volume Forecast
By Major Application
U.S.A., Molecular Diagnostic Market Forecast
By Major Application
U.S.A., Molecular Diagnostics Market
by Major Supplier

U.S. Tumor Markers Sales Segment Forecasts for over 40 Tests: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Tests, Technologies and Opportunities

This new report is a study of the major business opportunities emerging in the U.S. cancer diagnostics market during the next five years. The report examines trends in the U.S. cancer

USD 4500 View Report

U.S. Nucleic Acid Testing/NAT Market for 100 Assays: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing

This new 1,157-page report contains 65 tables, and presents a comprehensive analysis of the US molecular diagnostics market, including: Major issues pertaining to the US molecular diagnostics laboratory practice, as

USD 4850 View Report

Switzerland Nucleic Acid Testing (NAT) Market for 100 Assays: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing

This new report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years.Highlights- Five-year test

USD 3500 View Report

Sweden Nucleic Acid Testing (NAT) Market for 100 Assays: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing

This new report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years.Highlights- Five-year test

USD 3500 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available